retatrutide dosing frequency clinical trials Reta trial data & — a must read (Reta) isn't just another GLP-1. It's a triple-agonist peptide studied in Phase 3 for metabolic health — targeting GLP-1, GIP ✨ New Dosage Options &

Effects of liraglutide in the treatment of obesity: a randomized, double-blind, placebo-controlled study

These medicines had significant effects on gastrointestinal emptying and postprandial glucose regulation, but these effects were restricted to meals consumed quickly after administration (Nauck and Meier 2019)

Food and Drug Administration announced a new green list import alert aimed at stopping illegal and potentially dangerous GLP-1 drug ingredients from entering the country

Rigorously Third-Party Tested, Always Every product page includes independent lab test results for every peptide we sell

The Precision Peptide Genetic Test may help provide context on your individual predispositions in GLP1R, GIPR, and MC4R variants

Phentermine and topiramate ( Qsymia ): A metabolic stimulant combined with an anticonvulsant that helps dampen appetite